Birdwatch Note Rating
2023-10-04 19:40:27 UTC - HELPFUL
Rated by Participant: 989E4AF6BFA4E346DFF0D373ADCD1F8339DDA6D7CB2DC044311678F68ED50C22
Participant Details
Original Note:
Europe-based systematic reviews of evidence for the benefits and risks of puberty blockers and cross-sex hormones in Finland, Sweden, the Netherlands and England have concluded that the risk-benefit ratio of youth gender transition ranges from unknown to unfavourable. https://www.forbes.com/sites/joshuacohen/2023/06/06/increasing-number-of-european-nations-adopt-a-more-cautious-approach-to-gender-affirming-care-among-minors/?sh=48e997967efb
All Note Details